Your browser doesn't support javascript.
Modified SEIR and AI prediction of the epidemics trend of COVID-19 in China under public health interventions.
Yang, Zifeng; Zeng, Zhiqi; Wang, Ke; Wong, Sook-San; Liang, Wenhua; Zanin, Mark; Liu, Peng; Cao, Xudong; Gao, Zhongqiang; Mai, Zhitong; Liang, Jingyi; Liu, Xiaoqing; Li, Shiyue; Li, Yimin; Ye, Feng; Guan, Weijie; Yang, Yifan; Li, Fei; Luo, Shengmei; Xie, Yuqi; Liu, Bin; Wang, Zhoulang; Zhang, Shaobo; Wang, Yaonan; Zhong, Nanshan; He, Jianxing.
  • Yang Z; National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease (Guangzhou Medical University), Guangzhou 510230, China.
  • Zeng Z; Macau Institute for Applied Research in Medicine and Health, State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau, China.
  • Wang K; National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease (Guangzhou Medical University), Guangzhou 510230, China.
  • Wong SS; Hengqin WhaleMed Technology Co., Ltd., Zhuhai 519000, China.
  • Liang W; National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease (Guangzhou Medical University), Guangzhou 510230, China.
  • Zanin M; School of Public Health, The University of Hong Kong, Hong Kong, China.
  • Liu P; National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease (Guangzhou Medical University), Guangzhou 510230, China.
  • Cao X; National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease (Guangzhou Medical University), Guangzhou 510230, China.
  • Gao Z; School of Public Health, The University of Hong Kong, Hong Kong, China.
  • Mai Z; Jinling Institute of Technology, Nanjing Innovative Data Technologies, Inc., Nanjing 210014, China.
  • Liang J; Jinling Institute of Technology, Nanjing Innovative Data Technologies, Inc., Nanjing 210014, China.
  • Liu X; Jinling Institute of Technology, Nanjing Innovative Data Technologies, Inc., Nanjing 210014, China.
  • Li S; National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease (Guangzhou Medical University), Guangzhou 510230, China.
  • Li Y; National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease (Guangzhou Medical University), Guangzhou 510230, China.
  • Ye F; National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease (Guangzhou Medical University), Guangzhou 510230, China.
  • Guan W; National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease (Guangzhou Medical University), Guangzhou 510230, China.
  • Yang Y; National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease (Guangzhou Medical University), Guangzhou 510230, China.
  • Li F; National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease (Guangzhou Medical University), Guangzhou 510230, China.
  • Luo S; National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease (Guangzhou Medical University), Guangzhou 510230, China.
  • Xie Y; Transwarp Technologies (Shanghai) Co., Ltd., Shanghai 200030, China.
  • Liu B; Transwarp Technologies (Shanghai) Co., Ltd., Shanghai 200030, China.
  • Wang Z; Transwarp Technologies (Shanghai) Co., Ltd., Shanghai 200030, China.
  • Zhang S; National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease (Guangzhou Medical University), Guangzhou 510230, China.
  • Wang Y; Kunming University of Science and Technology, Kunming 650504, China.
  • Zhong N; National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease (Guangzhou Medical University), Guangzhou 510230, China.
  • He J; Hengqin WhaleMed Technology Co., Ltd., Zhuhai 519000, China.
J Thorac Dis ; 12(3): 165-174, 2020 Mar.
Article in English | MEDLINE | ID: covidwho-48351
ABSTRACT

BACKGROUND:

The coronavirus disease 2019 (COVID-19) outbreak originating in Wuhan, Hubei province, China, coincided with chunyun, the period of mass migration for the annual Spring Festival. To contain its spread, China adopted unprecedented nationwide interventions on January 23 2020. These policies included large-scale quarantine, strict controls on travel and extensive monitoring of suspected cases. However, it is unknown whether these policies have had an impact on the epidemic. We sought to show how these control measures impacted the containment of the epidemic.

METHODS:

We integrated population migration data before and after January 23 and most updated COVID-19 epidemiological data into the Susceptible-Exposed-Infectious-Removed (SEIR) model to derive the epidemic curve. We also used an artificial intelligence (AI) approach, trained on the 2003 SARS data, to predict the epidemic.

RESULTS:

We found that the epidemic of China should peak by late February, showing gradual decline by end of April. A five-day delay in implementation would have increased epidemic size in mainland China three-fold. Lifting the Hubei quarantine would lead to a second epidemic peak in Hubei province in mid-March and extend the epidemic to late April, a result corroborated by the machine learning prediction.

CONCLUSIONS:

Our dynamic SEIR model was effective in predicting the COVID-19 epidemic peaks and sizes. The implementation of control measures on January 23 2020 was indispensable in reducing the eventual COVID-19 epidemic size.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study / Prognostic study Language: English Journal: J Thorac Dis Year: 2020 Document Type: Article Affiliation country: Jtd.2020.02.64

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study / Prognostic study Language: English Journal: J Thorac Dis Year: 2020 Document Type: Article Affiliation country: Jtd.2020.02.64